Where does Boston Scientific Neuromodulation Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Boston Scientific Neuromodulation Corporation ranks #409 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Boston Scientific Neuromodulation Corporation hold?

Boston Scientific Neuromodulation Corporation holds 1,098 US utility patents granted between 2015 and 2025, spanning 48 technology areas.

What is Boston Scientific Neuromodulation Corporation's Innovation Score?

Boston Scientific Neuromodulation Corporation has an Innovation Score of 65.6 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Boston Scientific Neuromodulation Corporation's patent grant rate increasing or decreasing?

Boston Scientific Neuromodulation Corporation's recent grant velocity is -38% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Boston Scientific Neuromodulation Corporation's patents?

Boston Scientific Neuromodulation Corporation's patents average 19.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView US Corporation

Boston Scientific Neuromodulation Corporation

Q: What technology areas does Boston Scientific Neuromodulation Corporation focus on?

Boston Scientific Neuromodulation Corporation's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 1,080 patents. Grants appear in 48 CPC subclasses total.

Q: How is the Boston Scientific Neuromodulation Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 1,098 granted patents across 48 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Boston ranks #409 of 49,997 tracked US assignees by granted-patent volume, with 1,098 patents across 48 technology areas.

#409
of 49,997 US assignees by volume: Top 1%
by Innovation Score (65.6/100): 19.7
avg claims per patent: -38%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R409 · US Corporation #409 · 1,098 grants

GRANTS-LARGE · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-LARGE 1.1K grants
TOP-DECILE #409/49,997
PHOTO-FINISH Thomson Licensing
CPC-WIDE A61N · 48 areas
INNOV-STRONG 65.6/100
CLAIMS-RICH 19.7 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -38% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Thomson Licensing (±3 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Copeland · near

66
Ewha UNIVERSITY—INDU… · near

66
Ibiden · near

66
Boston Scientific… · this assignee

66
Bfly Operations · near

66
3D Lighting… · lowest

7

What this shows Boston's Innovation Score is 65.6/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Boston's grants concentrate

Boston Scientific Neuromodulation Corporation is a focused PatentsView assignee: 48 CPC subclasses with 98.4% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2016 (174 grants) versus a trough of 63 in 2022. By volume, Boston sits between Japan Aviation Electronics Industry, Limited and Bristol-Myers Squibb Company.

Boston's three-year grant acceleration

From 2019–2021 to 2022–2024, Boston Scientific Neuromodulation Corporation moved from 284 to 218 grants (0.77x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,943. See the growth leaderboard.

Japan Aviation In…

1,104
Elwha

1,103
Dropbox

1,102
Target Brands

1,102
Boston Scientific… ◀

1,098
Thomson Licensing

1,095
Advanced Semicond…

1,092
NTN

1,091
Bristol-myers Squ…

1,089

What this shows Boston holds 1,098 patents at rank #409, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Boston

By rank, the assignees closest to #409 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Boston's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Boston, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (66 here).

Ibiden Co., Ltd. 66 Bfly Operations, Inc. 66 Ewha UNIVERSITY—INDUSTRY Collaboration Foundation 66 Copeland LP 66

Similar claim depth

Nearest assignees by average claims per patent (19.7 here).

The Toronto-Dominion Bank 19.7 avg Corning Research & Development Corporation 19.7 avg Goldman Sachs & Co. LLC 19.7 avg Alderbio Holdings LLC 19.7 avg

Boston's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

66 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Boston Scientific Neuromodulation Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	129	11.7%
2016	174	15.8%
2017	134	12.2%
2018	97	8.8%
2019	106	9.7%
2020	93	8.5%
2021	85	7.7%
2022	63	5.7%
2023	73	6.6%
2024	82	7.5%
2025partial year	62	5.6%

Which technologies does Boston Scientific Neuromodulation Corporation patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1,080

A61B - DIAGNOSIS; SURGERY; Identification 231

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 141

Y10T - Technical Subjects Covered BY Former US Classification 63

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 45

H01R - Electrically-conductive CONNECTIONS; Structural Associations OF A Plurality OF Mutually-insulated Electrical Connecting ELEMENTS; Coupling DEVICES; Current Collectors 42

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 33

G06F - Electric Digital Data Processing 24

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 20

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 18

H04B - Transmission 17

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 12

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 11

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 11

H04W - Wireless Communication Networks 11

Top 15 of 48 technology areas

Where it ranks

Overall rank by patents

#409

of 49,997 tracked assignees

Innovation Score

65.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Boston Scientific Neuromodulation Corporation's patent record in context - here's where to go next.

Boston Scientific Neuromodulation Corporation's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 98.4% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #409 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Boston Scientific Neuromodulation Corporation against Japan Aviation Electronics Industry, Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 65.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.